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RESUMO
A doença de Parkinson é uma doença neurodegenerativa
entendida como uma síndrome complexa com sintomas motores
e não motores, incluindo condições relacionadas ao sono, como
movimentos periódicos dos membros durante o sono (MPMS).
Este artigo apresenta questões relacionadas à doença de
Parkinson, sintomas motores e não motores, fisiologia do sono e
MPMS. Em conclusão, ambas as condições parecem estar
correlacionadas por comprometimento do sistema
dopaminérgico.
Palavras-chave: Doença de Parkinson, sintomas não motores,
sono, movimento periódico dos membros.
¹ Programa de Pós-Graduação em Psiquiatria e Saúde Mental, Instituto de Psiquiatria, Federal University of Rio de Janeiro; 
² School of Medicine, Federal University of Rio de Janeiro
³ Institute of Neurology Deolindo Couto, School of Medicine, Federal University of Rio de Janeiro
Corresponding author: Dr Lucas Najar, llnajar@yahoo.com.br
Conflict of interest: There’s no conflict of interest to declare.
Funding: There’s no funding to declare.
ABSTRACT
Parkinson's disease is a neurodegenerative disease understood
as a complex syndrome with motor and non-motor symptoms,
including sleep-related conditions, such as periodic limb
movements in sleep (PLMS). This paper presents issues
regarding Parkinson's disease, motor and non-motor symptoms,
sleep physiology, and PLMS. In conclusion, both conditions
seem to be correlated through impairment of the dopaminergic
system.
Keywords: Parkinson's disease, nonmotor symptoms, sleep,
periodic limb movement.
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            Patients with Parkinson's disease (PD) have a
plethora of motor and non-motor symptoms. These last
include periodic limb movements in sleep (PLMS) that are
repetitive movements, most typically in the lower limbs.
However, periodic limb movement disorder (PLMD)
happens when patients with PLMS have associated clinical
sleep disturbance or a complaint of daytime fatigue. Both
PD and PLMD may respond to dopamine agonists. This
association raises many issues regarding shared
pathophysiology, as will be unfolded ¹ .
INTRODUCTION 
           The etiology of PD is poorly understood, but the
interaction between genetic factors and environmental risk
factors seems   to contribute to its neuropathogenesis.
Probably multiple etiologies contribute jointly to the
disease's development.
     Neuroimaging testing can provide diagnosis
confirmation and prevent possible misdiagnosis due to
PD's overlapping symptoms with other neurodegenerative
disorders, and DaTscan enables assessment of affected
nigrostriatal dopaminergic neurons terminals for PD
investigation. PD patients tend to have striatum (caudate
and putamen) minor signal on DaTscan related to
dopamine deficiency  .
             The predominant symptoms of PD are caused by
the loss of dopaminergic neurons in the substantia nigra,
and the nigrostriatal degeneration is a result of the
depletion and final loss of the neurotransmitter dopamine
at the synaptic terminals of striated neurons. As a result,
replacement therapy is required. Other functional brain
networks are also usually affected, such as those of mood,
behavior, and cognition. Also, PD is linked to the abnormal
presence of Lewy bodies, insoluble fibrillar aggregates
formed by a protein present in the human brain called
alpha-synuclein  .
               As presented in Figure 2, based on Braak et al.
2003 apud Keo et al.   the PD degenerative process would
begin in non-dopaminergic structures that ascends caudo-
rostrally from the lower brainstem and forebrain, into the
cerebral cortex. Six PD Braak´s stages are presented
sequentially depending on the accumulated Lewy bodies
during disease progression. This staging model implicates
environmental factors, such as toxins or inflammatory
agents, which can trigger the aggregation of α-synuclein,
the Lewy body, that come into contact with olfactory and/or
enteric neurons. The aggregated α-synuclein spreads
toward the central nervous system via the olfactory bulb
and the vagus nerve, but probably genetic factors are likely
to contribute to PD.
                  It is beyond the scope of this article to discuss the
mechanisms of formation and spread of the misfolded
prion-like alpha-synuclein through the brain and
synaptically coupled neuroanatomical tracts. However, this
would justify much earlier symptomatology when
compared to the classical one. It is illustrated in six
different stages. The former are marked by non-motor
symptoms, then motor symptoms often displayed around
the mid-stage state, and cognitive symptoms arising later.
PARKINSON'S DISEASE
         PD is a progressive neurodegenerative disease capable
of causing various motor and non-motor symptoms which
usually develop slowly, mainly affecting people over 65
years of age, with a predominance of males over females.
           The diagnosis of PD depends on the motor symptoms
caused by clinical effects of dopamine deficiency, so most
patients are usually diagnosed when the disease
progression is advanced and about 50% of dopaminergic
neurons in the substantia nigra (SN) are already absent,
with treatment start delay ² .
   Clinical effects of dopamine deficiency include
bradykinesia, rigidity, and tremor at rest, usually
manifesting asymmetrically, besides postural instability ².
Non- motor symptoms include mood disorders, autonomic
dysfunctions, fatigue, pain, cognitive changes,
gastrointestinal dysfunctions, perceptual distortions,
attention deficit and sleep disorders, which is one of the
commonly reported non-motor markers in patients with PD,
as well as in other neurodegenerative disorders (atypical
parkinsonian syndromes) 3 . Many of these symptoms are
included in Figure 1.
      Olfactory loss, REM sleep behavior disorder,
constipation and subtle motor parkinsonism are among the
strongest predictors to clinical PD presentation, and the
period lag between the onset of these symptoms and the
onset of PD varies from 5 years, for motor symptoms, to
over 20 years, for autonomic symptoms ² .
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SLEEP CHARACTERISTICS
         Sleep has an essential role in health, and around one-
third of the day is usually dedicated to it. Sleep allows
brain restoration when many sleep processes are carried
out, such as   defence against oxidative stress and
clearance of waste proteins from the brain through the
glymphatic system. Its lack induces many negative
repercussions, e.g., in heart, kidney disease, high blood
pressure, diabetes mellitus, memory loss, and stroke¹.
      Most adults need around 8 hours of sleep, but with
aging, due to decreased proportion of slow-wave sleep
periods, the propensity to sleep, as well as its duration,
decreases, and sleep become more fragmented.
          Sleep progresses through 4-6 cycles, each of
between 90 and 110 min, in a series of 4 stages of sleep
included in two main types of sleep, with brain wave
patterns particular to each one. There is Non-rapid eye
movement sleep (NREM sleep – N1, N2, and N3), and REM
sleep is characterized by rapid eye movement (REM),
increased breathing and brain activity¹. 
          Within the 24 hours of the sleep-wake circadian cycle,
determined by external and internal determinants, there is
also the ultradian cycle – sleep phases immersed in 4-6
cycles each night. The light/dark cycle resets the activity of
the suprachiasmatic nucleus (SCN), master pacemaker, via
the retina and the retinohypothalamic tract. Other
environmental stimuli can also entrain the SCN. Control of
the peripheral clocks mainly by the central pacemaker
occurs via a combination of neural and hormonal signals¹. 
     Paradoxical sleep is characterized by the brain and
other body systems higher activation accompanied by
higher muscle relaxation. This results in the expression of
dreams due to increased brain activity, but with voluntary
muscles immobilized. At the beginning of the night, NREM
sleep is more profound and proportionally higher.
However, as the night progresses, NREM sleep becomes 
more superficial, with a relatively higher presence of REM
sleep compared to the beginning of the night.
       The sleep-wake rhythm is one of the circadian rhythms
that include it and almost all other bodily processes such
as temperature, blood pressure, heart rate, hormone
secretion, physical, mental, and behavioral changes. These
rhythms respond to internal or external stimuli, mainly to
ambient lighting¹. 
       The SCN internally controls the circadian system. It is
the body's central biological clock in 24 hours of body
functions. The input to SCN comes from specialized retinal
ganglion cells that introduce light input and contribute to
the restart of the sleep-wake cycle. However, these
pathways are damaged in PD, as it occurs in dopaminergic
retinal degeneration¹.
     Melatonin levels increase at the end of the day,
signaling the night and preparing for sleep. Sleep and
basal ganglia disorders may have a common substrate,
and Hasegawa et al. suggest that the latter may play an
integral role in the sleep-wake cycle, specifically
contributing to an oscillatory network in slow-wave sleep,
which favors neural plasticity, besides the activity during
REM sleep would allow the action of cognitive and
emotional connections   .
Figure 2. Staging system PD progression proposed by Braak et al.
based on Keo et al. findings   .
Periodic limb movement in sleep and Parkinson's disease
      PD patients frequently present sleep disorders as
nonmotor symptoms, which have a great impact on their
quality of life. In Zhu et al's  cross-sectional study,
approximately one-quarter of the PD patients suffered
from sleep disturbances with a high prevalence of
cognitive dysfunction (39.8%). In these patients, a higher
percentage of sleep disorders was observed. In those with
cognitive dysfunction, the nonmotor symptoms –
hallucinations/delusions score was the most critical risk
factor for sleep disorders. Nonmotor symptoms in early-
stage PD are highly associated with the level of sleep
quality  . 
     The correlation between sleep disorders and PD is
reinforced by studies that show REM sleep behavior
disorder (RBD) as an early indicator for PD diagnosis  
 before motor symptoms, with present data insinuating
that up to 90% of patients with RBD develop some form of
parkinsonism. Studies also point out that excessive
daytime sleepiness may be present in both the early and
late stages of PD   .
       PLMS is diagnosed on a clinical and neurophysiological
basis, and it is recorded during Nocturnal
Polysomnography using anterior tibialis Electromyogram
(EMG) recordings. Besides, according to the American
Academy of Sleep Medicine (AASM), its diagnosis may be
given if the limb movements      : i. 0.5–10 sec in duration;
ii. Amplitude > 8 µV above baseline; iii. In a sequence of ≥ 4
movements; iv. Onsets of consecutive leg movements ≥ 5
and ≤ 90 sec. The PLMS must be distinguished from leg
movements that occur if the patient is waking up for other
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        Besides, there is Restless Legs Syndrome (RLS) that is
commonly associated with sleep disturbance and with PLMS. PLMS
and RLS are not the same. While the majority of RLS patients also
have PLMS, many patients with PLMS do not have RLS. There are
four main criteria for diagnosing RLS: irresistible need to move legs
that feel uncomfortable; symptoms occur or worsen when there is
inactivity; symptoms are relieved by moving the legs or rubbing
them; symptoms worsen at night.
        As already mentioned, PLMS presents as repetitive leg
movement during night sleep, which is recorded through PSG
(Figure 3). A study performed on 1107 subjects recruited from the
German population showed, regarding PLMSI >15/hour:  32.4%
prevalence,  besides a positive association, in at least one of the
cohorts, of factors like age, male gender, RLS, physical inactivity,
current smoking, diabetes, antidepressant use and lower serum
magnesium.  PLMS  indices  were higher  in   men, as  also occurs in
PD  . 
   However, more evidence suggests common
pathophysiological pathways, as nigrostriatal degeneration
can promote PLMS as well as PD, and there is also a
relationship between the number of leg movements and
the loss of nigrostriatal dopaminergic cells. In addition,
dopaminergic drugs provide benefits for PD and PLMS.
          Although RLS and PD are both related to central
dopaminergic dysfunction, there is no definitive evidence
of an association between both conditions   . There is no
clear pharmacological management of PLMS in PD
available, but the treatment of RLS includes avoidance of
medications known to exacerbate RLS and iron
replacement in individuals with proven iron deficiency.
Dopamine agonists are commonly used, but there is
concern regarding the possibility of augmentation
phenomenon¹.
Figure 3. Periodic leg movements during sleep (PLMS) were recorded on a
5-minute polysomnogram page, demonstrating 7 PLMs (circles) with
arousal peaks (arrows).
           Zhang et al.     performed a systematic review of the literature
exploring differences in PSG between PD patients and controls and
they concluded that PD patients have poor quantity and quality of
sleep. That work revealed an increased PLMI in PD patients when
compared to healthy controls    , and in the study by Covassin et   
 al.     it was found to be more common in patients with PD of
higher severity.
        PLM has been suggested to be associated with a shallower and
fragmented sleep in the general population, such as an increased
amount of stage N1 and decreased slow-wave sleep (SWS). This is
consistent with the findings that increased PLMI of PD patients is
associated with increased N1 and decreased SWS percentage in PD
patients when compared to controls, suggesting that PLMS is a
significant contributor to PSG measured sleep abnormalities in PD
patients. 
       The pathophysiology of PLMS is unknown, but there are reports
of a negative correlation between the binding of the striatal tracer
and PLMI, as reported in a study of PSG and SPECT   . As for the
pathophysiology of PLMS during PD sleep, it is also not fully
understood. However, a reduction in striatal dopamine transporter
binding has been suggested in PD patients with PLMS compared to
those without PLMS. Furthermore, given the importance of the
dopaminergic system in sleep-wake regulation, sleep quality may
be worse in parkinsonian patients with PLMS compared to those
without it. Thus, the affected dopaminergic system could impact on
sleep of PD patients, by increasing PLMI     .
CONCLUSION
There is a higher prevalence of PLMS in PD and similar
pathophysiology between them.
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